Skip to main content
SpringerLink
Log in

Mechanical Circulatory Support to Bridge to a Long-Term Continuous-Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation

  • Chapter
  • First Online:
Mechanical Circulatory Support for Advanced Heart Failure

  • 1221 Accesses

Abstract

The use of mechanical circulatory support (MCS) devices as a bridge to transplantation is becoming increasingly popular. Short-term MCS has become a necessary component of the therapeutic strategy for patients in cardiogenic shock, and short-term MCS devices are now being implanted as a bridge to decision. The purpose of using short-term MCS to bridge to decision is to stabilize a patient’s hemodynamic status and improve end-organ function to reduce surgical risks before implanting left ventricular assist devices (LVAD). Appropriate patient selection is the central tenet of the current paradigm of MCS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008;86(4):1227–34; discussion 1234–25.

    Google Scholar 

  2. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4 Suppl):S1–39.

    Article  PubMed  Google Scholar 

  3. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51.

    Article  CAS  PubMed  Google Scholar 

  4. Rich MW, Keller AJ, Schechtman KB, Marshall WG Jr, Kouchoukos NT. Increased complications and prolonged hospital stay in elderly cardiac surgical patients with low serum albumin. Am J Cardiol. 1989;63(11):714–8.

    Article  CAS  PubMed  Google Scholar 

  5. Gracin N, Johnson MR, Spokas D, et al. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation. J Heart Lung Transplant. 1998;17(10):1017–23.

    CAS  PubMed  Google Scholar 

  6. Oz MC, Goldstein DJ, Pepino P, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995;92(9 Suppl):II169–73.

    Article  CAS  PubMed  Google Scholar 

  7. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg. 2003;125(4):855–62.

    Article  PubMed  Google Scholar 

  8. Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 1997;16(8):822–31.

    CAS  PubMed  Google Scholar 

  9. Schulman AR, Martens TP, Christos PJ, et al. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2007;133(3):841–2.

    Article  PubMed  Google Scholar 

  10. Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall SA. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117(10):1622–8.

    Article  PubMed  Google Scholar 

  11. Shah D. Does targeting ibutilide-resistant CFAE improve outcomes for catheter ablation of persistent AF? Eur Heart J. 2016;37(20):1622–5.

    Article  PubMed  Google Scholar 

  12. Boyle AJ, Ascheim DD, Russo MJ, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant. 2011;30(4):402–7.

    Article  PubMed  Google Scholar 

  13. Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33(1):12–22.

    Article  PubMed  Google Scholar 

  14. Miller LW, Guglin M. Patient selection for ventricular assist devices: a moving target. J Am Coll Cardiol. 2013;61(12):1209–21.

    Article  PubMed  Google Scholar 

  15. Gray BW, Haft JW, Hirsch JC, Annich GM, Hirschl RB, Bartlett RH. Extracorporeal life support: experience with 2,000 patients. ASAIO J. 2015;61(1):2–7.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hoefer D, Ruttmann E, Poelzl G, et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg. 2006;82(1):28–33.

    Article  PubMed  Google Scholar 

  17. Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg. 2001;71(3 Suppl):S77–81; discussion S82–75.

    Google Scholar 

  18. Rastan AJ, Dege A, Mohr M, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139(2):302–11, 311.e1.

    Google Scholar 

  19. Kawashima D, Gojo S, Nishimura T, et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J. 2011;57(3):169–76.

    Article  PubMed  Google Scholar 

  20. Beurtheret S, Mordant P, Pavie A, Leprince P. Impella and extracorporeal membrane oxygenation: a demanding combination. ASAIO J. 2012;58(3):291–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiothoracic Transplant and Mechanical Circulatory Support, Texas Heart Institute at Baylor St. Luke’s Medical Center, Baylor College of Medicine, Houston, TX, USA

    Chitaru Kurihara M.D.

Authors
  1. Chitaru Kurihara M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chitaru Kurihara M.D. .

Editor information

Editors and Affiliations

  1. Division of Cardiothoracic Transplantation, Surgical Director, Mechanical Circulatory Support and Cardiac Transplantation, Texas Heart Institute at Baylor St. Luke’s Medical Center, Baylor College of Medicine, Houston, Texas, USA

    Jeffrey A. Morgan

  2. Medical Director, Heart Transplant Program, Co-Director, Advanced Heart Failure Center, Texas Heart Institute at Baylor St. Luke’s Medical Center, Baylor College of Medicine, Houston, Texas, USA

    Andrew B. Civitello

  3. Center for Cardiac Support, Texas Heart Institute at Baylor St. Luke’s Medical Center, Baylor College of Medicine, Houston, Texas, USA

    O.H. Frazier

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kurihara, C. (2018). Mechanical Circulatory Support to Bridge to a Long-Term Continuous-Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation. In: Morgan, J., Civitello, A., Frazier, O. (eds) Mechanical Circulatory Support for Advanced Heart Failure . Springer, Cham. https://doi.org/10.1007/978-3-319-65364-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65364-8_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65363-1

  • Online ISBN: 978-3-319-65364-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation